Status | 已發表Published |
Discovery and preliminary SAR of 14-aryloxy-andrographolide derivatives as antibacterial agents with immunosuppressant activity | |
Li, F; Li, XM; Sheng, D; Chen, SR; Nie, X; Liu, Z; Wang, D; Wang, Y. T.; Zhao, Q.; Wang, Y.; Zhou, GC | |
2018-03-01 | |
Source Publication | RSC Advances |
ISSN | 2046-2069 |
Pages | 9440-9456 |
Abstract | Antibacterials (which restore gut flora balance) and immunosuppressants (which correct immune defects)are two important and effective therapeutic agents for the treatment of inflammatory bowel disease (IBD) in clinical use today. Since the structural skeleton of andrographolide, isolated from Andrographis paniculata, has become known as a natural antibiotic with anti-inflammation and heat-clearing and detoxifying properties, 14-aryloxy andrographolide derivatives have been designed, synthesized, and tested for their antibacterial effects on E. coli S. aureus, and E. faecalis, which are related to IBD. It has been discovered , in this study that the andrographolide skeleton is more selective against E. faecalis, the 14-aryloxy group with basicity is important for antibacterial functions, and the 14-(80-quinolinyloxy) group is a good pharmacophore with antibacterial activity. In addition, we found that 7b1 and 8b1 are good and selective inhibitors of E. faecalis; two 14b-(80-quinolinyloxy) andrographolide derivatives, 6b17 and 9b, exhibit good activity against E. coli, S. aureus, and E. faecalis. Likewise and importantly, further exploration of immunosuppressant activity for IBD shows that compound 7b1 is a selective inhibitor of the TNF-a/NF- kB signaling pathway, whereas 8b1 is selectively active against the TLR4/NF-kB signaling pathway;moreover, the compounds 6b17 and 9b are active in inhibiting the IL-6/STAT3, TLR4/NF-kB, and TNF-a/ NF-kB signaling pathways. Based on these results, we have further focused on the development of dual function inhibitors of IBD as antibacterial and immunosuppressant agents by structural modification of andrographolide. |
Keyword | SAR andrographolide antibacterial agents immunosuppressant activity. |
Language | 英語English |
The Source to Article | PB_Publication |
PUB ID | 35804 |
Document Type | Journal article |
Collection | Institute of Chinese Medical Sciences |
Corresponding Author | Wang, Y.; Zhou, GC |
Recommended Citation GB/T 7714 | Li, F,Li, XM,Sheng, D,et al. Discovery and preliminary SAR of 14-aryloxy-andrographolide derivatives as antibacterial agents with immunosuppressant activity[J]. RSC Advances, 2018, 9440-9456. |
APA | Li, F., Li, XM., Sheng, D., Chen, SR., Nie, X., Liu, Z., Wang, D., Wang, Y. T.., Zhao, Q.., Wang, Y.., & Zhou, GC (2018). Discovery and preliminary SAR of 14-aryloxy-andrographolide derivatives as antibacterial agents with immunosuppressant activity. RSC Advances, 9440-9456. |
MLA | Li, F,et al."Discovery and preliminary SAR of 14-aryloxy-andrographolide derivatives as antibacterial agents with immunosuppressant activity".RSC Advances (2018):9440-9456. |
Files in This Item: | There are no files associated with this item. |
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment